학술논문
INTERLEUKIN 8 PROMOTER POLYMORPHISM PREDICTS THE INITIAL RESPONSE TO BEVACIZUMAB TREATMENT FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
Document Type
Article
Author
Source
Retina: The Journal of Retinal & Vitreous Diseases; Oct2013, Vol. 33 Issue 9, p1815-1827, 13p
Subject
Language
ISSN
0275004X